Pan-Cancer Analysis of Mutation Hotspots in Protein Domains

Cell Systems

Volumn 1, Issue 3, 2015, Pages 197-209

  Miller, Martin L ^a,b   Reznik, Ed ^a   Gauthier, Nicholas P ^a   Aksoy, Bülent Arman ^a   Korkut, Anil ^a   Gao, Jianjiong ^a   Ciriello, Giovanni ^a   Schultz, Nikolaus ^a   Sander, Chris ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CARCINOGENESIS; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; NEOPLASM; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ALIGNMENT; SOMATIC MUTATION;

EID: 84942254387     PISSN: 24054712     EISSN: 24054720     Source Type: Journal    
DOI: 10.1016/j.cels.2015.08.014     Document Type: Article

References (63)

1. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, and S.R. Sunyaev A method and server for predicting damaging missense mutations Nat. Methods 7 2010 248 249
2. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, S.A.J.R. Aparicio, S. Behjati, A.V. Biankin, G.R. Bignell, N. Bolli, A. Borg, A.-L. Børresen-Dale, et al. Australian Pancreatic Cancer Genome Initiative ICGC Breast Cancer Consortium ICGC MMML-Seq Consortium ICGC PedBrain Signatures of mutational processes in human cancer Nature 500 2013 415 421
3. D. Bell, A. Berchuck, M. Birrer, J. Chien, D.W. Cramer, F. Dao, R. Dhir, P. DiSaia, H. Gabra, P. Glenn, et al. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
4. M.J. Betts, Q. Lu, Y. Jiang, A. Drusko, O. Wichmann, M. Utz, I.A. Valtierra-Gutiérrez, M. Schlesner, N. Jaeger, D.T. Jones, and et al. Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions Nucleic Acids Res. 43 2015 e10
5. Y. Bromberg, G. Yachdav, and B. Rost SNAP predicts effect of mutations on protein function Bioinformatics 24 2008 2397 2398
6. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
7. P. Carlsson, and M. Mahlapuu Forkhead transcription factors: key players in development and metabolism Dev. Biol. 250 2002 1 23
8. E. Cerami, E. Demir, N. Schultz, B.S. Taylor, and C. Sander Automated network analysis identifies core pathways in glioblastoma PLoS ONE 5 2010 e8918
9. E. Cerami, J. Gao, U. Dogrusoz, B.E. Gross, S.O. Sumer, B.A. Aksoy, A. Jacobsen, C.J. Byrne, M.L. Heuer, E. Larsson, and et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Cancer Discov. 2 2012 401 404
10. L.C. Cerchietti, K. Hatzi, E. Caldas-Lopes, S.N. Yang, M.E. Figueroa, R.D. Morin, M. Hirst, L. Mendez, R. Shaknovich, P.A. Cole, and et al. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy J. Clin. Invest. 120 2010 4569 4582
11. C. Chothia, J. Gough, C. Vogel, and S.A. Teichmann Evolution of the protein repertoire Science 300 2003 1701 1703
12. Y.P. Chu, C.H. Chang, J.H. Shiu, Y.T. Chang, C.Y. Chen, and W.J. Chuang Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: insight into its domain swapping and DNA binding Protein Sci. 20 2011 908 924
13. G. Ciriello, E. Cerami, C. Sander, and N. Schultz Mutual exclusivity analysis identifies oncogenic network modules Genome Res. 22 2012 398 406
14. C.J. Creighton, M. Morgan, P.H. Gunaratne, D.A. Wheeler, R.A. Gibbs, A. Gordon Robertson, A. Chu, R. Beroukhim, K. Cibulskis, S. Signoretti, et al. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43 49
15. N.D. Dees, Q. Zhang, C. Kandoth, M.C. Wendl, W. Schierding, D.C. Koboldt, T.B. Mooney, M.B. Callaway, D. Dooling, E.R. Mardis, and et al. MuSiC: identifying mutational significance in cancer genomes Genome Res. 22 2012 1589 1598
16. N.J. Dibb, S.M. Dilworth, and C.D. Mol Switching on kinases: oncogenic activation of BRAF and the PDGFR family Nat. Rev. Cancer 4 2004 718 727
17. L. Ding, G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, M.B. Morgan, and et al. Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
18. N.I. Fleming, R.N. Jorissen, D. Mouradov, M. Christie, A. Sakthianandeswaren, M. Palmieri, F. Day, S. Li, C. Tsui, L. Lipton, and et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer Cancer Res. 73 2013 725 735
19. J. Gao, B.A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross, S.O. Sumer, Y. Sun, A. Jacobsen, R. Sinha, E. Larsson, and et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal Sci. Signal. 6 2013 pl1
20. L.A. Garraway, and E.S. Lander Lessons from the cancer genome Cell 153 2013 17 37
21. A. Gonzalez-Perez, and N. Lopez-Bigas Functional impact bias reveals cancer drivers Nucleic Acids Res. 40 2012 e169
22. S.F. Göthel, and M.A. Marahiel Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts Cell. Mol. Life Sci. 55 1999 423 436
23. C. Greenman, P. Stephens, R. Smith, G.L. Dalgliesh, C. Hunter, G. Bignell, H. Davies, J. Teague, A. Butler, C. Stevens, and et al. Patterns of somatic mutation in human cancer genomes Nature 446 2007 153 158
24. H. Greulich, B. Kaplan, P. Mertins, T.-H. Chen, K.E. Tanaka, C.-H. Yun, X. Zhang, S.-H. Lee, J. Cho, L. Ambrogio, and et al. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2 Proc. Natl. Acad. Sci. USA 109 2012 14476 14481
25. P.S. Hammerman, M.S. Lawrence, D. Voet, R. Jing, K. Cibulskis, A. Sivachenko, P. Stojanov, A. McKenna, E.S. Lander, S. Gabriel, et al. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
26. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
27. M. Hofree, J.P. Shen, H. Carter, A. Gross, and T. Ideker Network-based stratification of tumor mutations Nat. Methods 10 2013 1108 1115
28. L. Holm, and C. Sander Mapping the protein universe Science 273 1996 595 603
29. B.S. Jaiswal, N.M. Kljavin, E.W. Stawiski, E. Chan, C. Parikh, S. Durinck, S. Chaudhuri, K. Pujara, J. Guillory, K.A. Edgar, and et al. Oncogenic ERBB3 mutations in human cancers Cancer Cell 23 2013 603 617
30. C. Kandoth, N. Schultz, A.D. Cherniack, R. Akbani, Y. Liu, H. Shen, A.G. Robertson, I. Pashtan, R. Shen, C.C. Benz, et al. Cancer Genome Atlas Research Network Integrated genomic characterization of endometrial carcinoma Nature 497 2013 67 73
31. D.C. Koboldt, R.S. Fulton, M.D. McLellan, H. Schmidt, J. Kalicki-Veizer, J.F. McMichael, L.L. Fulton, D.J. Dooling, L. Ding, E.R. Mardis, et al. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours Nature 490 2012 61 70
32. M.S. Lawrence, P. Stojanov, P. Polak, G.V. Kryukov, K. Cibulskis, A. Sivachenko, S.L. Carter, C. Stewart, C.H. Mermel, S.A. Roberts, and et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes Nature 499 2013 214 218
33. M.S. Lawrence, P. Stojanov, C.H. Mermel, J.T. Robinson, L.A. Garraway, T.R. Golub, M. Meyerson, S.B. Gabriel, E.S. Lander, and G. Getz Discovery and saturation analysis of cancer genes across 21 tumour types Nature 505 2014 495 501
34. J.C. Lee, I. Vivanco, R. Beroukhim, J.H.Y. Huang, W.L. Feng, R.M. DeBiasi, K. Yoshimoto, J.C. King, P. Nghiemphu, Y. Yuza, and et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain PLoS Med. 3 2006 e485
35. X. Liu, L. Wang, K. Zhao, P.R. Thompson, Y. Hwang, R. Marmorstein, and P.A. Cole The structural basis of protein acetylation by the p300/CBP transcriptional coactivator Nature 451 2008 846 850
36. J.G. Lohr, P. Stojanov, M.S. Lawrence, D. Auclair, B. Chapuy, C. Sougnez, P. Cruz-Gordillo, B. Knoechel, Y.W. Asmann, S.L. Slager, and et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing Proc. Natl. Acad. Sci. USA 109 2012 3879 3884
37. D.S. Marks, L.J. Colwell, R. Sheridan, T.A. Hopf, A. Pagnani, R. Zecchina, and C. Sander Protein 3D structure computed from evolutionary sequence variation PLoS ONE 6 2011 e28766
38. D.S. Marks, T.A. Hopf, and C. Sander Protein structure prediction from sequence variation Nat. Biotechnol. 30 2012 1072 1080
39. R. McLendon, A. Friedman, D. Bigner, E.G. Van Meir, D.J.M. Brat, G. Mastrogianakis, J.J. Olson, T. Mikkelsen, N. Lehman, K. Aldape, et al. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
40. R.D. Morin, M. Mendez-Lago, A.J. Mungall, R. Goya, K.L. Mungall, R.D. Corbett, N.A. Johnson, T.M. Severson, R. Chiu, M. Field, and et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature 476 2011 298 303
41. N.L. Nehrt, T.A. Peterson, D. Park, and M.G. Kann Domain landscapes of somatic mutations in cancer BMC Genomics 13 Suppl 4 2012 S9
42. P.C. Ng, and S. Henikoff SIFT: Predicting amino acid changes that affect protein function Nucleic Acids Res. 31 2003 3812 3814
43. N. Ohtaki, A. Yamaguchi, T. Goi, T. Fukaya, K. Takeuchi, K. Katayama, K. Hirose, and T. Urano Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis Int. J. Oncol. 18 2001 265 270
44. L. Pasqualucci, D. Dominguez-Sola, A. Chiarenza, G. Fabbri, A. Grunn, V. Trifonov, L.H. Kasper, S. Lerach, H. Tang, J. Ma, and et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma Nature 471 2011 189 195
45. M. Peifer, L. Fernández-Cuesta, M.L. Sos, J. George, D. Seidel, L.H. Kasper, D. Plenker, F. Leenders, R. Sun, T. Zander, and et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Nat. Genet. 44 2012 1104 1110
46. T.A. Peterson, A. Adadey, I. Santana-Cruz, Y. Sun, A. Winder, and M.G. Kann DMDM: domain mapping of disease mutations Bioinformatics 26 2010 2458 2459
47. T.A. Peterson, N.L. Nehrt, D. Park, and M.G. Kann Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer J. Am. Med. Inform. Assoc. 19 2012 275 283
48. M. Punta, P.C. Coggill, R.Y. Eberhardt, J. Mistry, J. Tate, C. Boursnell, N. Pang, K. Forslund, G. Ceric, J. Clements, and et al. The Pfam protein families database Nucleic Acids Res. 40 2012 D290 D301
49. J. Reimand, and G.D. Bader Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers Mol. Syst. Biol. 9 2013 637
50. J. Reimand, O. Wagih, and G.D. Bader The mutational landscape of phosphorylation signaling in cancer Sci. Rep. 3 2013 2651
51. B. Reva, Y. Antipin, and C. Sander Predicting the functional impact of protein mutations: application to cancer genomics Nucleic Acids Res. 39 2011 e118
52. Y. Shi, A. Hata, R.S. Lo, J. Massagué, and N.P. Pavletich A structural basis for mutational inactivation of the tumour suppressor Smad4 Nature 388 1997 87 93
53. J.C. Stroud, Y. Wu, D.L. Bates, A. Han, K. Nowick, S. Paabo, H. Tong, and L. Chen Structure of the forkhead domain of FOXP2 bound to DNA Structure 14 2006 159 166
54. A. Torkamani, and N.J. Schork Identification of rare cancer driver mutations by network reconstruction Genome Res. 19 2009 1570 1578
55. K.L. Tsai, C.Y. Huang, C.H. Chang, Y.J. Sun, W.J. Chuang, and C.D. Hsiao Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins J. Biol. Chem. 281 2006 17400 17409
56. N.J. Wang, Z. Sanborn, K.L. Arnett, L.J. Bayston, W. Liao, C.M. Proby, I.M. Leigh, E.A. Collisson, P.B. Gordon, L. Jakkula, and et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma Proc. Natl. Acad. Sci. USA 108 2011 17761 17766
57. A.P. Weng, A.A. Ferrando, W. Lee, J.P. Morris 4th, L.B. Silverman, C. Sanchez-Irizarry, S.C. Blacklow, A.T. Look, and J.C. Aster Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia Science 306 2004 269 271
58. J.W. Wu, M. Hu, J. Chai, J. Seoane, M. Huse, C. Li, D.J. Rigotti, S. Kyin, T.W. Muir, R. Fairman, and et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling Mol. Cell 8 2001 1277 1289
59. Y. Wu, M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, J.C. Stroud, D.L. Bates, L. Guo, A. Han, S.F. Ziegler, and et al. FOXP3 controls regulatory T cell function through cooperation with NFAT Cell 126 2006 375 387
60. J.Y. Wu, C.J. Yu, Y.C. Chang, C.H. Yang, J.Y. Shih, and P.C. Yang Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Clin. Cancer Res. 17 2011 3812 3821
61. F. Yang, E. Petsalaki, T. Rolland, D.E. Hill, M. Vidal, and F.P. Roth Protein domain-level landscape of cancer-type-specific somatic mutations PLoS Comput. Biol. 11 2015 e1004147
62. P. Yue, E. Melamud, and J. Moult SNPs3D: candidate gene and SNP selection for association studies BMC Bioinformatics 7 2006 166
63. P. Yue, W.F. Forrest, J.S. Kaminker, S. Lohr, Z. Zhang, and G. Cavet Inferring the functional effects of mutation through clusters of mutations in homologous proteins Hum. Mutat. 31 2010 264 271